Everyone diagnosed with cancer deserves to be treated with the latest state-of-the-art technology, promising new treatments and drugs and receive timely care.
There are a wide range of national initiatives to improve cancer treatment and care that Surrey and Sussex Cancer Alliance is supporting to deliver locally.
Investing in new diagnostic equipment
The NHS Long Term Plan makes a commitment to invest in new equipment, including CT and MRI Scanners, which can deliver faster and safer results and complete the £130 million upgrade of radiotherapy machines.
Royal Surrey NHS Foundation Trust was among the first three hospital trusts in the South East region to benefit from investment in linear accelerators (LINACs).
Creating radiotherapy networks
By forming radiotherapy networks and working collaboratively – across traditional organisational boundaries – we can share expertise, technology and treatment techniques. In doing so, we will be able to improve cancer survival and reduce variation in care.
The NHS Long Term Plan sets out commitment over the next ten years to routinely offer genomic testing to all people with cancer for whom it would be of clinical benefit. This will help ensure cancer treatments are better targeted to the person.
Cancer waiting times
Cancer waiting time standards are set nationally and are used to measure the quality of cancer care and improve waiting times for patients.
We work with the acute (hospital) trusts and clinical commissioning groups in our area to help them achieve the standards. This work includes:
- Undertaking a review of the demand on, and capacity of, services. This will help us target investment in the most challenged hospitals so that we can increase capacity in cancer services and see more patients within the set timeframes.
- Looking at the way cancer services are commissioned across the three health and care systems we support so that we can better balance supply of, and demand on, services.
- Working with local health and care systems to implement the National Timed Pathways for lung, prostate and colorectal cancers, and from 2020, oesophago-gastric cancer.
Find out more about the cancer waiting time standards.